Every cancer treatment plan rests on one document most patients never learn to question: the pathology report. It names the disease, grades it, and, increasingly, determines which drugs a patient even qualifies for. It's also written by a single pathologist, working from a single set of slides, often under real time pressure.
For most of those reports, the diagnosis holds up on a second look. But not always, and understanding what a "pathology review" actually is, and when it's worth requesting one, is the part patients rarely walk through.
Your pathology report can determine its type, grade, and sometimes which treatments may be appropriate. Patients choose a US lab for a second opinion because of access to highly specialized pathologists, subspecialty expertise, and advanced diagnostic testing available at major cancer centres.
Having another expert review the original slides can confirm the diagnosis, identify differences in interpretation, or provide greater clarity before treatment begins. Here’s what the review involves, when it may help, and how it can influence your care.
What Does "Pathology Review" Actually Mean?
A pathology review is the process of a pathologist examining tissue, from a biopsy, needle aspiration, or surgery, under a microscope, often alongside molecular or immunohistochemical (IHC) stains, to determine exactly what the disease is, how aggressive it looks, and which biomarkers it carries. The written result of that process is the pathology report you're handed.
An expert pathology opinion is not a new procedure and not a repeat biopsy. It's a different, often subspecialized, pathologist re-examining the same physical slides, or a digital scan of them, independently, without necessarily knowing what the first pathologist concluded. What's typically re-examined:
| Element reviewed | Why it's relevant to your care |
|---|---|
| Cell type / histologic subtype | Determines what kind of cancer it actually is |
| Grade | Signals how the cancer is likely to behave |
| Margins | Whether removed tissue's edges are clear of cancer |
| Lymph node involvement | Feeds directly into staging |
| Biomarkers (ER/PR/HER2, PD-L1, etc.) | Determines eligibility for specific drug classes |
Why the Pathology Report Carries So Much Weight
Every downstream decision, which chemotherapy regimen, whether surgery is curative-intent or not, radiation dosing, and eligibility for targeted therapy or clinical trials, is built on the pathology diagnosis, not on imaging alone. The National Comprehensive Cancer Network's (NCCN) treatment framework makes this sequence explicit: diagnosis feeds pathology, pathology feeds stage and biomarkers, and only then does treatment selection happen.
If that first link in the chain is off, everything attached to it, the surgical plan, the drug regimen, the prognosis conversation, is built on the wrong foundation. That's the entire rationale behind pathology review existing as a distinct, well-documented practice, rather than something only unusually cautious patients pursue.
When a Pathology Review Is Actually Worth Requesting
There's no rule that fits every patient, but a review tends to matter most when:
- An irreversible treatment is next: mastectomy, organ removal, or high-dose radiation to a critical structure
- The diagnosis is rare, unusual, or hard to classify: some cancer subtypes look nearly identical under a microscope but behave very differently
- The report itself signals uncertainty: language like "suspicious," "atypical," "indeterminate," "favor," or "cannot exclude" is a cue worth asking about
- The original biopsy sample was small: needle biopsies can be diagnostic, but limited tissue sometimes makes grading or biomarker testing harder
- Imaging or symptoms don't quite match the report
- Treatment eligibility hinges on a specific biomarker: before a targeted therapy or a clinical trial that requires biomarker confirmation
- The original diagnosis came from a smaller or general pathology lab, ahead of treatment at a larger specialty center
The American Cancer Society's own second-opinion guidance backs this up in practical terms: it recommends patients keep a copy of their pathology report on hand and explicitly supports asking two doctors to review a case together.
So, if your diagnosis is uncertain or treatment decisions are significant, Arbuda can connect you and your treating physician with a US specialist for an expert pathology review, before treatment moves forward.
Pathology Second Opinion vs. Oncology (Treatment) Second Opinion
These two get used interchangeably, but they answer different questions entirely:
| Pathology second opinion | Oncology (treatment) second opinion | |
|---|---|---|
| What's reviewed | Tissue slides, blocks, stains, biomarker tests | Diagnosis, imaging, stage, medical history, proposed treatment plan |
| Who does it | A pathologist, often subspecialized | A specialist oncologist or multidisciplinary tumor board |
| Core question | Is this diagnosis accurate and complete? | Given this diagnosis, is this the right treatment plan? |
| Typical turnaround | Often a matter of days | Longer — may involve a full tumor board discussion |
What Actually Happens During a Pathology Second Opinion
1. Materials are requested: The original slides, tissue blocks, or a digital whole-slide scan, from the lab or hospital that performed the original biopsy or surgery.
2. Materials are transferred, physically by courier or digitally, to the reviewing pathology department.
3. A pathologist, often with subspecialty training in that cancer type, re-examines the tissue, sometimes ordering additional stains or molecular tests not run the first time.
4. A written second-opinion report is issued, which the treating physician compares line-by-line against the original.
5. The patient and oncologist discuss what, if anything, should change about the treatment plan.
The unglamorous part is step 1 and 2: authorization forms, courier logistics, sometimes a direct fee from the reviewing lab, and, for patients outside the US, shipping and customs considerations for physical slides. This is usually where the process quietly stalls for people managing it without help.
This is where having the right support can make the process easier. Arbuda helps coordinate the practical aspects of an expert pathology review, working alongside your treating physician, so patients can focus on understanding their diagnosis and treatment options.
Where Arbuda Fits Into This Process
Arbuda is a patient support platform complements your existing cancer care by connecting you and your treating physician with additional US-based oncology experts in pathology and other specialties. Rather than positioning an expert review against your local doctor, Arbuda brings specialized expertise into the team already managing your care.
Arbuda’s core service is an Expert Opinion, a structured review of your diagnosis, pathology, treatment plan, and available options. The review is coordinated with your treating physician, so the recommendations can be considered alongside the care you are already receiving.
The process typically involves:
- Finding the right specialists: Arbuda connects your case with appropriate US-based oncology experts for pathology or other subspecialty review.
- Managing medical records: The team coordinates relevant clinical documents, pathology slides, digital scans, and other records required for review.
- Arranging consultations: Online consultations can be organized with US-based specialists to discuss findings with you and, where appropriate, your treating physician.
- Simplifying coordination: Arbuda provides a central point of contact for documentation, communication, scheduling, and international coordination. Your local physician remains responsible for directing your ongoing care. If specialized treatment, a clinical trial, an advanced procedure, or care at another center becomes relevant, Arbuda can help facilitate the next steps.
If you’re trying to figure out whether an expert opinion makes sense for your situation, Arbuda’s team can help you and your treating physician connect with a US specialist to talk it through.
Chat with Arbuda's team to get connected with a US-based specialist.
Medical Disclaimer: This article is for general educational purposes only and does not constitute medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a qualified oncologist or pathologist about your specific case. Arbuda is a technology-enabled patient navigation platform and does not provide medical diagnoses or treatment.
